Aqua Metals, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Aqua Metals, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.10M | Mar 15, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $25.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.0K | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $173.0K | Mar 9, 2023 |
| FY2020 | Dec 31, 2020 | $0 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $90.0K | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $18.0K | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $593.0K | Feb 25, 2021 |
| FY2020 | Sep 30, 2019 | $2.36M | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($22.65M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($24.56M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($23.94M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($15.43M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($18.19M) | Mar 9, 2023 |
| FY2020 | Dec 31, 2020 | ($15.52M) | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | ($1.84M) | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | ($3.98M) | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | ($4.43M) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | ($11.27M) | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($23.33M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($23.85M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($24.46M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($15.57M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($17.47M) | Mar 9, 2023 |
| FY2020 | Dec 31, 2020 | ($4.15M) | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | ($3.41M) | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | ($3.77M) | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | ($4.06M) | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | ($10.28M) | Feb 25, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.57M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $1.37M | Mar 15, 2018 |
| FY2017 | Jun 30, 2017 | $2.18M | Mar 15, 2018 |
| FY2017 | Mar 31, 2017 | $2.99M | Mar 15, 2018 |
| FY2017 | Dec 31, 2016 | $2.27M | Mar 15, 2018 |
| FY2017 | Sep 30, 2016 | $1.89M | Mar 15, 2018 |
| FY2017 | Jun 30, 2016 | $1.31M | Mar 15, 2018 |
| FY2017 | Mar 31, 2016 | $883.0K | Mar 15, 2018 |
| FY2016 | Dec 31, 2015 | $1.10M | Mar 2, 2017 |
| FY2016 | Sep 30, 2015 | $546.0K | Mar 2, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.25M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($13.63M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($3.19M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($10.15M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($7.06M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($11.03M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | ($25.18M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($26.32M) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | ($19.00M) | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | ($11.12M) | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $425.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.92M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.60M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $4.77M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.35M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $3.36M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $12.80M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.69M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $8.82M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $29.16M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.71M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $26.37M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $33.60M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $33.50M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $33.27M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $35.14M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $69.45M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $71.37M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $74.44M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $71.53M | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.94M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $10.12M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $7.54M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $12.59M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $5.74M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $4.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $19.87M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $21.28M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $15.48M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $14.54M | Mar 15, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.77M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $16.24M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | $26.06M | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $20.92M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $27.53M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $31.14M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $49.59M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $50.09M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $58.97M | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $56.99M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($270.42M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($247.77M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($223.22M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($199.28M) | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | ($183.85M) | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | ($165.65M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | ($139.89M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($95.10M) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | ($54.84M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($28.26M) | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.81M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.08M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $16.52M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $7.08M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $8.14M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $6.53M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $7.58M | Feb 25, 2021 |
| FY2018 | Dec 31, 2018 | $20.89M | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | $22.79M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $25.46M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $332.0K | Feb 25, 2021 |
| FY2019 | Dec 31, 2019 | $9.31M | Mar 11, 2020 |
| FY2018 | Dec 31, 2018 | $9.55M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $9.92M | Mar 15, 2018 |
| FY2015 | Dec 31, 2015 | $10.02M | Mar 28, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (15) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (38) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (5) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 9, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.00M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 773,084 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 5.39M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 79.48M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 70.42M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 64.46M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 58.00M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 38.93M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | 27.55M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 17.88M | Mar 15, 2018 |